Failure to monitor ticlopidine: the case for clopidogrel

Author： Richardson Gail Curzen Nicholas P Preston Melanie A Mills Peter G Timmis Adam D Rothman Martin T

ISSN： 1471-1796

Source： International Journal of Cardiovascular Interventions, Vol.3, Iss.1, 2000-03, pp. : 29-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

VASOMODULATORY ACTION OF CLOPIDOGREL AND TICLOPIDINE

By Yang L.H. Fareed J.

Thrombosis Research, Vol. 86, Iss. 6, 1997-06 ,pp. : 479-491

Elsevier

Access to resources Recommend Favorite

Modulation of Vasoconstriction by Clopidogrel and Ticlopidine - A new safe and effective antiplatelet agent. But unanswered questions remain

By Yang L.H. Hoppensteadt D. Fareed J.

Thrombosis Research, Vol. 92, Iss. 2, 1998-10 ,pp. : 83-89

Elsevier

Access to resources Recommend Favorite

A Randomized, Double-Blind Study Comparing the Safety and Efficacy of Clopidogrel versus Ticlopidine in Japanese Patients with Noncardioembolic Cerebral Infarction

Cerebrovascular Diseases, Vol. 25, Iss. 1-2, 2007-11 ,pp. : 40-49

Karger

Access to resources Recommend Favorite

Prasugrel as alternative treatment strategy in a case with a hypersensitivity reaction to clopidogrel

By van Werkum Jochem W. Braber Thijs L. Verheggen Peter W. H. M. Van Der Have-Roeffel Simone M.

Platelets, Vol. 22, Iss. 1, 2011-02 ,pp. : 75-76

Informa Healthcare

Access to resources Recommend Favorite

Failure of clopidogrel to reduce platelet reactivity and activation following standard dosing in elective stenting: implications for thrombotic events and restenosis

By Gurbel Paul A. Samara Waiel M. Bliden Kevin P.

Platelets, Vol. 15, Iss. 2, 2004-03 ,pp. : 95-99

Informa Healthcare

Access to resources Recommend Favorite